CELEX: 62018TA0359
Language: en
Date: 2019-09-19 00:00:00
Title: Case T-359/18: Judgment of the General Court of 19 September 2019 — Unifarco v EUIPO — GD Tecnologie Interdisciplinari Farmaceutiche (TRICOPID) (EU trade mark — Opposition proceedings — Application for EU word mark TRICOPID — Earlier national figurative mark TRICODIN — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)

25.11.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 399/49
            
         
      Judgment of the General Court of 19 September 2019 — Unifarco v EUIPO — GD Tecnologie Interdisciplinari Farmaceutiche (TRICOPID)
      (Case T-359/18) (1)
      
      (EU trade mark - Opposition proceedings - Application for EU word mark TRICOPID - Earlier national figurative mark TRICODIN - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)
      (2019/C 399/58)
      Language of the case: Italian
      
         Parties
      
      
         Applicant: Unifarco SpA (Santa Giustina, Italy) (represented by: A. Perani and J. Graffer, lawyers)
      
         Defendant: European Union Intellectual Property Office (represented by: L. Rampini, acting as Agent)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: GD Tecnologie Interdisciplinari Farmaceutiche Srl (Rome, Italy) (represented by: E. Pepe and M. Farinola, lawyers)
      
         Re:
      
      Action brought against the decision of the Fifth Board of Appeal of EUIPO of 13 March 2018 (Case R 2150/2017-5), relating to opposition proceedings between GD Tecnologie Interdisciplinari Farmaceutiche and Unifarco.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  
                     Dismisses the action;
                  
               
            
                  2.
               
               
                  
                     Orders Unifarco SpA to pay the costs, including those incurred by GD Tecnologie Interdisciplinari Farmaceutiche Srl before the Board of Appeal of the European Union Intellectual Property Office (EUIPO).
                  
               
            
         (1)  OJ C 276, 6.8.2018.